FGF21 and metabolic syndrome: Consistently, treatment with FGF-21 has been confirmed to improve the energy metabolism in hepatocytes in both rodents and non-human primates, supporting that FGF21 could be considered as a potential therapeutic method for dyslipidemia [40].